Trials / Completed
CompletedNCT05891275
Patients With Geographic Atrophy and Their Patient Journey in the United States (US)
Characterization of Patients With Geographic Atrophy (GA) in the US
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 68,563 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To quantify and describe patients with a Geographic Atrophy (GA) diagnosis in at least one eye, and the progression to neovascular Age-Related Macular Degeneration (including how many receive Anti-VEGF), or to GA (in the fellow eye only).
Conditions
Timeline
- Start date
- 2023-05-31
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-06-06
- Last updated
- 2025-05-01
- Results posted
- 2025-05-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05891275. Inclusion in this directory is not an endorsement.